Clinical Trials Browser

Phase 2 × Breast Neoplasms × Leuprolide × Clear all

NCT04569747 2026-04-02

ADEPT

Phase 2 Active not recruiting

Breast Neoplasms

NCT04293393 2026-03-12

CARABELA

Phase 2 Active not recruiting

200 enrolled 27 charts

Breast Neoplasms

NCT07158021 2026-02-13

Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial

Phase 2 Recruiting

Breast Neoplasms

NCT03056755 2026-01-13

BYLieve

Phase 2 Completed

383 enrolled 16 charts

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT07159451 2025-12-01

POP-ELA

Phase 2 Recruiting

Breast Neoplasms

NCT03944434 2025-02-26

FACILE

Phase 2 Active not recruiting

Breast Neoplasms

NCT03900637 2024-07-31

PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate

Phase 2 Active not recruiting

Breast Neoplasms

NCT03272477 2024-04-17

TP-II

Phase 2 Completed

Breast Neoplasms

NCT01989780 2022-08-04

BOOSTER

Phase 2 Completed

Breast Neoplasms

NCT02344550 2020-07-30

LEO

Phase 2 Completed

Breast Neoplasms

NCT02592746 2019-04-08

A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC

Phase 2 Unknown

Breast Neoplasms

NCT02689921 2018-09-28

NEOADAPT

Phase 2 Unknown

Breast Neoplasms

NCT03497702 2018-04-13

NeoChAI

Phase 2 Unknown

Breast Neoplasms

NCT00903162 2016-04-18

Extended Endocrine Therapy for Premenopausal Women With Breast Cancer

Phase 2 Completed

17 enrolled 5 charts

Breast Neoplasms

NCT00498901 2013-05-09

Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer

Phase 2 Terminated

Breast Neoplasms